| OHSU # 1684 | Hydrolysis-Resistant Local Anesthetics | Jeffrey Karpen, Sarah Kirk, Adriana Andrade, Kenneth Melich, Michelle Schaffer |
| OHSU # 1325 | Compounds for treating parasitic disease. | Michael Riscoe, Rolf Winter, David Hinrichs |
| OHSU # 1295 | Naphthamides as anticancer agents inhibiting CREB-mediated gene transcription | Xiangshu Xiao, Bingbing Li |
| OHSU # 1004 | Aromatic ketones and uses thereof. | Michael Riscoe, Rolf Winter, Jane Kelly, Martin Smilkstein, David Hinrichs |
| OHSU # 0725 | New selective estrogen receptor modulator (SERM) | Martin Kelly, Oline Ronnekleiv, Jian Qiu, Thomas Scanlan, Sandra Tobias |
| OHSU # 0640 | POMC transgenic mice and neuron-specific promoter | Malcolm Low, Marcelo Rubinstein, Flavio Silva de Souza |
| OHSU # 0496 | Method of Treating Immune Pathologies with Low Dose Estrogen | Halina Offner |
| OHSU # 0367 | Methods and Reagents for Using Mammalian Melanocortin Receptor Agonists and Antagonists to Modulate Feeding Behavior in Animals (MC3&4) | Roger Cone, Wei Fan, Bruce Boston, Robert Kesterson, Dongsi Lu, Wenbiao Chen |
| OHSU # 0349 | Opioid Antagonists and Methods of Their Use (Orphanin & analogs) | David Grandy, Judith Grisel, Jeffrey Mogil, James Bunzow, Rainer Reinscheid, Hans-Peter Nothacker, Rick Monsma, Olivier Civelli |
| OHSU # 0346 | Mammalian Opioid Receptor Ligand and Uses (Orphanin FQ) | David Grandy, James Bunzow, Olivier Civelli, Rainer Reinscheid, Hans-Peter Nothacker, Rick Monsma |
